Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 3
1950 1
1951 1
1952 1
1954 1
1969 3
1973 1
1974 2
1976 3
1977 2
1978 2
1979 1
1980 2
1982 2
1983 1
1984 1
1985 1
1987 2
1989 1
1990 1
1991 1
1992 3
1993 2
1994 6
1995 3
1996 3
1997 6
1998 5
1999 6
2000 6
2001 2
2002 3
2003 7
2004 11
2005 5
2006 10
2007 6
2008 9
2009 9
2010 7
2011 16
2012 5
2013 7
2014 10
2015 10
2016 6
2017 4
2018 10
2019 4
2020 5
2021 10
2022 19
2023 17
2024 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Results by year

Filters applied: . Clear all
Page 1
Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug Conjugate.
Hobson AD, McPherson MJ, Hayes ME, Goess C, Li X, Zhou J, Wang Z, Yu Y, Yang J, Sun L, Zhang Q, Qu P, Yang S, Hernandez A Jr, Bryant SH, Mathieu SL, Bischoff AK, Fitzgibbons J, Santora LC, Wang L, Wang L, Fettis MM, Li X, Marvin CC, Wang Z, Patel MV, Schmidt DL, Li T, Randolph JT, Henry RF, Graff C, Tian Y, Aguirre AL, Shrestha A. Hobson AD, et al. J Med Chem. 2022 Dec 8;65(23):15893-15934. doi: 10.1021/acs.jmedchem.2c01579. Epub 2022 Nov 17. J Med Chem. 2022. PMID: 36394224
An anti-TNF-glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases.
McPherson MJ, Hobson AD, Hernandez A Jr, Marvin CC, Waegell W, Goess C, Oh JZ, Shi D, Hayes ME, Wang L, Wang L, Schmidt D, Wang Z, Pitney V, McCarthy K, Jia Y, Wang C, Kang BN, Bryant S, Mathieu S, Ruzek M, Parmentier J, D'Cunha RR, Pang Y, Phillips L, Brown NJ, Xu J, Graff C, Tian Y, Longenecker KL, Qiu W, Zhu H, Liu W, Zheng P, Bi Y, Stoffel R. McPherson MJ, et al. Among authors: hobson ad. Sci Transl Med. 2024 Mar 20;16(739):eadd8936. doi: 10.1126/scitranslmed.add8936. Epub 2024 Mar 20. Sci Transl Med. 2024. PMID: 38507467
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC).
Hobson AD, Xu J, Welch DS, Marvin CC, McPherson MJ, Gates B, Liao X, Hollmann M, Gattner MJ, Dzeyk K, Sarvaiya H, Shenoy VM, Fettis MM, Bischoff AK, Wang L, Santora LC, Wang L, Fitzgibbons J, Salomon P, Hernandez A Jr, Jia Y, Goess CA, Mathieu SL, Bryant SH, Larsen ME, Cui B, Tian Y. Hobson AD, et al. J Med Chem. 2023 Sep 14;66(17):12544-12558. doi: 10.1021/acs.jmedchem.3c01174. Epub 2023 Sep 1. J Med Chem. 2023. PMID: 37656698
ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignancies.
Chang CA, Emberley E, D'Souza AL, Zhao W, Cosgrove C, Parrish K, Mitra D, Payson E, Oleksijew A, Ellis P, Rodriguez L, Duggan R, Hrusch C, Lasko L, Assaily W, Zheng P, Liu W, Hernandez A Jr, McCarthy K, Zhang Z, Rha G, Cao Z, Li Y, Perng O, Campbell J, Zhang G, Curran T, Bruncko M, Marvin CC, Hobson A, McPherson M, Uziel T, Pysz MA, Zhao X, Bankovich A, Hayflick J, McDevitt M, Freise KJ, Morgan-Lappe S, Purcell JW. Chang CA, et al. Among authors: hobson a. Blood. 2024 Aug 15;144(7):757-770. doi: 10.1182/blood.2024023849. Blood. 2024. PMID: 38701407 Free PMC article.
Entrepreneurship during a pandemic.
Storr VH, Haeffele S, Lofthouse JK, Hobson A. Storr VH, et al. Among authors: hobson a. Eur J Law Econ. 2022;54(1):83-105. doi: 10.1007/s10657-021-09712-7. Epub 2021 Nov 3. Eur J Law Econ. 2022. PMID: 35924086 Free PMC article.
Clopidogrel "resistance": where are we now?
Qureshi Z, Hobson AR. Qureshi Z, et al. Among authors: hobson ar. Cardiovasc Ther. 2013 Feb;31(1):3-11. doi: 10.1111/j.1755-5922.2011.00296.x. Epub 2011 Aug 3. Cardiovasc Ther. 2013. PMID: 21884029 Free article. Review.
An insight into the functional alterations in the gut microbiome of healthy adults in response to a multi-strain probiotic intake: a single arm open label trial.
Rodenes-Gavidia A, Lamelas A, Bloor S, Hobson A, Treadway S, Haworth J, Vijayakumar V, Naghibi M, Day R, Chenoll E. Rodenes-Gavidia A, et al. Among authors: hobson a. Front Cell Infect Microbiol. 2023 Sep 29;13:1240267. doi: 10.3389/fcimb.2023.1240267. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37841999 Free PMC article. Clinical Trial.
257 results